FDA Orders Psychiatric Warn Labels On Asthma Drugs
By Liz McKenzie · June 12, 2009, 12:00 AM EDT
The U.S. Food and Drug Administration has asked AstraZeneca Pharmaceuticals LP, Merck & Co. Inc. and Cornerstone Therapeutics Inc. to update the labeling for their leukotriene modifiers class of asthma drugs...
To view the full article, register now.